Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    

| More

BUY on Galaxy Surfactants - Higher per unit EBITDA leads profitability - ICICI Securities

Posted On: 2020-07-02 04:41:19

Mr. Nilesh Ghuge & Mr. Harshad Katkar, Institutional Research Analyst, HDFC Securities.

Galaxy Surfactants (Q4FY20 Results Review): Higher per unit EBITDA leads profitability. BUY
(TP Rs 1900, CMP Rs 1479, MCap Rs 52bn)

Our BUY recommendation on GALSURF with a TP of INR 1,900 is premised on ((1) 55% revenues come from MNCs, which ensures stickiness of business, (2) EBITDA margins are stable at >12% since fluctuations in RMC are easily passed through to customers, and (3) Strong return ratios (RoE/RoIC of 26.3/24.1% in FY22).

View on the result: EBITDA/APAT were 31/40% above expectations as vols were 13% higher than anticipated at 58.1kT.

Despite vol growth, lower RMC result in a muted top-line: In 4Q, revenue jumped 5% QoQ to INR 7bn attributable to (1) 7% jump in overall volumes, (2) Offset by, 3% decline in per unit realisation as RMC declined by 1% (direct pass on to customers). In FY20, despite the 4.4% YoY jump in blended vols, revenue declined by 6% YoY to INR 26bn as per unit realisation dropped by 10% YoY (RMC per tonne decline 15%).

Dramatic improvement in margins: RMC per unit declined by 15% while realisation declined by 10% only. This has resulted in higher Gross margins to 36.3% (+374/473bps QoQ/YoY). EBITDA margins improved as well to 15.6% (+250/166bps YoY/QoQ).

Operational performance: FY20 volumes grew 4.4% YoY to 224kT, led by Performance Surfactants (+6% YoY) to 144kT. Specialty care (36% of vol mix) grew 2% YoY to 81kT. Blended vols growth was largely driven by the Africa/Middle East/Turkey (AMET) market +9% YoY (42% of vol mix) followed by 1% jump in vols sold in the Rest of the World (25% of mix).

Outlook on consolidated EBITDA: We expect EBITDA to dip by 20% YoY in FY21 to INR 3bn dragged by 19% dip in per ton EBITDA to INR 13K and muted volume outlook given supply side restrictions because of Covid-19. In FY22, EBITDA should jump 81%YoY to INR 5bn led by 17/55% increase in blended vols/per unit EBITDA to 260kT/INR 20.6K per ton. This is owing to recovery in global demand and greater stress on personal hygiene.

View on the consolidated balance sheet: The company's cash jumped 2.4x YoY to INR 603mn leading to a 5% YoY dip in Net debt to INR 2,593mn. Consequently, Net Debt/Equity and Net Debt/EBITDA reduced to 0.2/0.7x vs. 0.3x/0.8x in FY19. RoE/RoIC remained at a steady 23/19% in FY20 vs. 24/18% in FY19 and 24/17% in FY18.

Change in estimates: We raise our FY22E EPS estimate by 9% to INR 93.5 in anticipation of faster recovery in demand.

DCF based valuation: Our TP is INR 1,900 based on Sep-21E cash flows (WACC 10%, Terminal growth rate 3.0%). The stock is trading at 15.8x FY22 EPS.

Shares of Galaxy Surfactants Ltd was last trading in BSE at Rs.1558.5 as compared to the previous close of Rs. 1479.45. The total number of shares traded during the day was 3436 in over 667 trades.

The stock hit an intraday high of Rs. 1564.45 and intraday low of 1485. The net turnover during the day was Rs. 5292954.

Source: Equity Bulls

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Cadila Healthcare - Q1FY21 First Cut - ICICI Securities

Dwarikesh Sugar - Q1FY21 First Cut - ICICI Securities

Jyothy Lab - Q1FY21 First Cut - ICICI Securities

Avenue Supermarts - Company Update - August 2020 - ICICI Securities

Hawkins Cookers - 1QFY21 Results - Angel Broking

Maintain REDUCE on Godrej Consumers - Strong comeback in H1 - HDFC Securities

ADD on Gujarat Gas - A complete washout quarter - HDFC Securities

SELL on Vinati Organics - At an inflexion point - HDFC Securities

Expectations from the upcoming RBI Policy - HDFC Securities

AXIS Bank - 10,000 Cr QIP - Angel Broking

PI Industries - Mr. Jyoti Roy, DVP - Equity Strategist, Angel Broking Ltd.

Maintain BUY on Teamlease Services - Recovery on the cards ICICI Securities

Reiterate ADD on Tata Motors - Volatile environment - ICICI Securities

Tata Consumer Products Ltd - 1QFY21 results - Rajit Rajoriya, Equity Research Associate, Angel Broking Ltd

Maintain REDUCE On Karur Vysya Bank - Pain inevitable - HDFC Securities

Sovereign Gold Bonds - Thematic Report - ICICI Securities

Varun Beverages - Q2CY20 Result Update - ICICI Securities

Saregama India - Company Update - August 2020 - ICICI Securities

Exide Industries - Q1FY21 Result Update - ICICI Securities

Indian Oil Corporation - Q1FY21 Result Update - ICICI Securities

Maintain ADD on Indian Oil Corporation - High inventory losses drag earnings - HDFC Securities

Maintain BUY on Cholamandalam Investment & Finance - A mostly good show - HDFC Securities

Maintain ADD on BSE - Fighting its way back - HDFC Securities

Maintain ADD on Motilal Oswal Financial Services - In-line performance - HDFC Securities

Maintain BUY on Sobha - A smooth ride with few bumps - HDFC Securities

Banking Sector Credit Trends Report - Growth slows, as expected - HDFC Securities

Maintain ADD on Sun Pharma - Cost savings drive the quarterly beat - HDFC Securities

Auto Sector Performance - July'20 - Angel Broking

Sector Thematic on Indian Gas Sector - Looking beyond the pandemic - HDFC Securities

ADD on Max Financial - Lower margins despite higher protection - HDFC Securities

Maintain BUY on Mastek - Changing orbit - HDFC Securities

Mantain REDUCE On Dabur - In-line 2Q, slight beat in domestic volume - HDFC Securities

CreditAccess Grameen - Q1FY21 - YES Securities

ADD on Torrent Pharma - Resilient performance - HDFC Securities

BSE Limited - Pricing pressure remains a challenge - ICICI Securities

Kansai Nerolac Paints - Better-than-expected trajectory in decorative paints -

VA Tech Wabag - High receivables, low margins to impact earnings - ICICI Securities

CreditAccess Grameen - Customer activation trend shows resilience - ICICI Securities

Tata Chemicals - Q1FY21 Result Update - ICICI Securities

VST Industries - Q1FY21 Result Update - ICICI Securities

ADD on Navin Fluorine International - Commendable performance - HDFC Securities

Whirlpool of India - Valuations belie outlook; risk-reward unfavourable - ICICI Securities

Kansai Nerolac - Q1FY21 First Cut - ICICI Securities

Exide Industries - Q1FY21 First Cut - ICICI Securities

Monthly Auto Volumes - July, 2020 - ICICI Securities

Cholamandalam Investments and Finance Company Ltd - Q1FY21 Result Update - YES Securities

Mahindra logistics - Q1FY21 Result Update - YES Securities

Bluedart Express - Q1FY21 Result Update - YES Securities

Tata Motors - Cost improvements reassuring - ICICI Securities

Godrej Agrovet - Deflation in input prices leads to higher margin - ICICI Securities

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019